 BioNTech SE NASDAQ: BNTX and Matinas BioPharma Holdings Inc NYSE: MTNB have entered into an exclusive research collaboration to evaluate the combination of mRNA formats and Matinas proprietary LNC platform technology. The companies will collaborate on. 